Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 16, Number 18, 2010

Articles

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

The Effects of Acute Tryptophan Depletion on Brain Activation During Cognition and Emotional Processing in Healthy Volunteers
pp. 1998-2011(14)
Authors: Evers, E.A.T.; Sambeth, A.; Ramaekers, J.G.; Riedel, W.J.; van der Veen, F.M.

Favourites:
ADD

FMRI, Antipsychotics and Schizophrenia. Influence of Different Antipsychotics on BOLD-Signal
pp. 2012-2025(14)
Authors: H. Roder, Christian; Marie Hoogendam, Janna; M. van der Veen, Frederik

Favourites:
ADD

Dopaminergic Modulation of Cognitive Control: Distinct Roles for the Prefrontal Cortex and the Basal Ganglia
pp. 2026-2032(7)
Authors: van Schouwenburg, Martine; Aarts, Esther; Cools, Roshan

Favourites:
ADD

Prodrug Design of Phenolic Drugs
pp. 2033-2052(20)
Authors: Ferriz, J.M.; Vinsova, J.

Favourites:
ADD

Current Nervous System Related Drug Targets for the Treatment of Amyotrophic Lateral Sclerosis
pp. 2053-2073(21)
Authors: C. Pawlyk, Aaron; A. Cassel, Joel; B. Reitz, Allen

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content